Curidium Medica


Curidium is developing diagnostic tools that can be used to assess how individual patients will respond to treatments. Homomatrix is a technology that can identify specific patient subgroups. This can help doctors to prescribe the most appropriate treatment to a patient, which is known as personalised medicine. The main focus is central nervous system (CNS) ailments but the same diagnostics platform could be used as a basis for other medical areas. Curidium was established in 2001 and it reversed into Cielo Holdings in July 2006. On 8 March 2008, 30 shares were consoldiated in one new share.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds